Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-12

Clinical Trial Update: Lactobacillus Johnsonii Supplementation in Adults With T1D [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Lactobacillus Johnsonii supplementation in adults with Type 1 diabetes mellitus; the study is currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus Johnsonii (Lactobacillus Johnsonii)

Snippet

Sponsor: University of Florida | Conditions: Type 1 Diabetes (T1D) | Phase 2 | Status: ACTIVE_NOT_RECRUITING